Non-pvc infusion bag

Non-PVC infusion bags are primarily made from multi-layer co-extruded films (such as PP, SEBS, or PE). The most significant advantage is the absence of DEHP (plasticizers), which prevents toxic chemicals from leaching into the medication. These bags offer superior drug compatibility, especially for fat-soluble drugs and chemotherapy agents, and are environmentally friendly as they do not release hydrochloric acid or dioxins during incineration.

Buyers must ensure products comply with ISO 15747 (Plastic containers for intravenous injections). Key technical parameters include water vapor permeability rates, transparency (light transmission >80%), and pressure resistance (ability to withstand 0.5-1 bar for 15 minutes). For international trade, verify CE Marking (MDR 2017/745) for Europe, FDA 510(k) for the US, and GMP (Good Manufacturing Practice) certification of the facility.

Modern designs feature dual-port or multi-port systems to separate the injection and infusion channels, reducing the risk of cross-contamination. Look for self-sealing medicinal ports that can withstand multiple punctures without leaking. Additionally, the outer packaging (overwrap) is critical; it should provide an oxygen barrier and moisture protection to extend the shelf life of the IV fluids.

The bags must be capable of withstanding high-pressure steam sterilization (typically 121°C for 15-30 minutes) without deformation or sticking. Suppliers should provide validation reports for sterility assurance levels (SAL of 10^-6). Ensure the material maintains flexibility and impact resistance even after the thermal sterilization process.

Always request a Pre-Shipment Inspection (PSI) by a third-party agency like SGS or Intertek. Focus on leakage tests, particulate matter contamination, and tensile strength of the seals. For long-term reliability, prioritize suppliers on Made-in-China.com who hold 'Audited Supplier' status, as this confirms their manufacturing capacity and legal existence.

Negotiate based on Total Cost of Ownership (TCO) rather than just the unit price. Discuss MOQ flexibility for trial batches (e.g., 10,000 - 50,000 units) before moving to full-scale production. Demand a Quality Agreement that specifies the compensation protocol for defective rates exceeding 0.5%, and ensure the supplier provides Batch Records for every shipment to ensure traceability.

Infusion bags are bulky but lightweight; therefore, freight volume (CBM) significantly impacts costs. Use vacuum-sealed inner packaging to save space and prevent contamination. Ensure the HS Code (typically 392690 or 901890) is correctly declared to avoid customs delays. For sensitive medical plastics, avoid shipping during extreme heat seasons or use temperature-controlled containers to prevent material degradation.

Utilize Trade Assurance services provided by platforms like Made-in-China.com to protect your payment until the goods are verified. For large orders, use a Letter of Credit (L/C) or a staged payment plan (e.g., 30% deposit, 70% against Bill of Lading) to balance the risk between the buyer and the seller.